OTIS BRUNSON
JACKSON, MS
Browse related groups: MS Incyte Corporation All categories
This page merges CMS profile IDs: 11254042, 11310505 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$2,661.60
- Category: General Payments
- Program years: PY2021–2024
- Record count: 133
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,046.12 across 54 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,046.12 | 54 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $163.70 | 8 |
| Janssen Biotech, Inc. | $110.56 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $101.52 | 5 |
| Astellas Pharma US Inc | $70.43 | 4 |
| Celgene Corporation | $68.73 | 3 |
| PFIZER INC. | $64.56 | 4 |
| Merck Sharp & Dohme Corporation | $49.78 | 3 |
| Karyopharm Therapeutics Inc. | $48.62 | 3 |
| ADC Therapeutics America, Inc. | $38.90 | 2 |
| E.R. Squibb & Sons, L.L.C. | $37.96 | 2 |
| SpringWorks Therapeutics, Inc. | $36.03 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $35.53 | 2 |
| Exelixis Inc. | $26.53 | 1 |
| ABBVIE INC. | $26.29 | 1 |
| Immunocore Limited | $24.70 | 1 |
| Lilly USA, LLC | $20.78 | 1 |
| Acerta Pharma LLC | $19.64 | 1 |
| AVEO Pharmaceuticals, Inc. | $19.05 | 1 |
| EMD Serono, Inc. | $18.13 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $17.90 | 1 |
| Genmab U.S., Inc. | $16.53 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.40 | 1 |
| GENZYME CORPORATION | $13.85 | 1 |
By program year
Records — PY2024 (54)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 11254042, 11310505
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.